Phase 3 sABI Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Intravenous pentoxifylline as adjunct therapy to improve long-term disability in preterm infants
Late-onset sepsis (LOS)Preterm infantsNecrotising enterocolitis (NEC)+1 more
University of Sydney1,800 enrolled25 locationsACTRN12616000405415
Completed
Phase 3
Australasian Antenatal Study To Evaluate the Role Of Intramuscular Dexamethasone versus Betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial
Long-term childhood neurosensory disability following antenatal corticosteroids given to women at risk of preterm birth at less than 34 weeks gestatation
Women’s and Children’s Hospital, SA1,499 enrolled1 locationACTRN12608000631303
Not Yet Recruiting
Phase 3
Motor Skills Project
Children with physical disabilities - cerebral palsyDown's syndrome
Australian Physiotherapy Association20 enrolled1 locationACTRN12605000749606
Completed
Phase 3
Optimising very preterm infant outcomes: an evidence based screening and surveillance method
Disability of very preterm infant
The University of Queensland202 enrolled1 locationACTRN12606000472572